Join us for interactive, informative webinar to help acquaint you with the well-respected Online MS Degree Program in Applied PharmacoEconomics or Managed Care Pharmacy Systems, from the University of Florida. In this 1-hour webinar, we will cover: Program Overview of the Online MS […]
Use the Search feature on the website to find archived webinars by key word. If you’d like to promote a featured webinar to increase viewership by an average of 20%, contact us for advertising opportunities.
To learn more about promoting webinars on-demand, read our blog posting: Good to Great: Webinar Success Strategies.
The potential of natural language processing (NLP) and AI-based tools to accelerate screening and data extraction in systematic reviews continues to be a hot topic in evidence-based research. If you are involved in conducting systematic reviews, you’ve probably wondered whether artificial […]
Pre-Recorded Webinar Entrepreneurial regulation is a philosophy that allows agencies such as the FDA to be both regulator and colleague to the industry. In such an environment, regulators gain the ability to: Develop policies that are an incentive for innovative medicines Advance the […]
Sponsored by Evidence Partners, this tutorial will take attendees through the process of creating, managing and updating systematic literature reviews using the Distiller suite of literature review tools. Find out more here. (Source: American Medical Writers association) […]
So you need to conduct a systematic review for clinical evidence, economic evaluations, or comparative effectiveness, but you aren’t sure that your process is as thorough, efficient, or complete as it should be. How can you make sure you are using the most efficient and up-to-date Best Practices? […]
Webinar recorded on July 20, 2016 Provisions passed under Section 114 of the Food and Drug Administration Modernization Act of 1997 (FDAMA Section 114) established an evidentiary standard for promotional dissemination of health care economic data. However, neither regulations nor guidance in […]
Health Technology Assessment (HTA) agencies consider a wide range of evidence when evaluating drugs for reimbursement, but their appraisals do not indicate the weight or importance of individual evidence sources. Using Scottish Medicines Consortium (SMC) as a case study, we compared positive vs. […]